Skip to main content

Cti Biopharma Corp

CTICDelisted Jun 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0000891293

Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Cti Biopharma Corp changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CTIC: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders145133−12
Shares105.1M113.1M+8.09M (+7.7%)
Value$619.8M$475.2M−$144.6M (−23.3%)

New holders (17)

Institutions that held Cti Biopharma Corp at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CTIC in Q1 2023
InstitutionSharesValue% of portfolio
Rubric Capital Management LP8,963,256$37.6M1.50%
Marshall Wace, LLP5,960,103$25.0M0.06%
Ally Bridge Group (NY) LLC550,000$2.31M3.03%
Profund Advisors LLC208,517$875.8K0.05%
Wells Fargo & Company207,270$870.5K0.00%
Tejara Capital Ltd110,000$462.0K0.24%
Ergoteles LLC70,371$295.6K0.01%
Qube Research & Technologies Ltd60,459$253.9K0.00%
Jefferies Financial Group Inc.32,680$137.3K0.00%
Walleye Trading LLC26,581$111.6K0.00%
XTX Topco Ltd23,073$96.9K0.02%
CM Wealth Advisors LLC16,308$81.0K0.02%
Quantbot Technologies LP17,900$75.2K0.01%
Wolverine Trading, LLC15,764$67.0K0.00%
Centiva Capital, LP12,292$51.6K0.00%
Sawtooth Solutions, LLC10,200$42.8K0.00%
Allworth Financial LP1$50.00%

Sold out (29)

Institutions that held Cti Biopharma Corp at the end of Q4 2022 and filed for Q1 2023 without it.